English

BIOATLA, INC.

EDGAR

BCAB Current report (8-K) · filed 2026-10-20

42 filing records in this dataset, filed from 2020-11-13 to 2026-10-20. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2023 Q3 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-27.3 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -74093000 USD Source
Operating Cash Flow: -46748000 USD Source

Cash and cash equivalents: 1.54 million USD 2026-06-30 Source
Exact value

1544000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 1.66 million shares 2026-06-30 Source
Exact value

1663280 shares

Reported share-count change

-97.17% · -57.1 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

58721588 shares · 2025-06-30· Source
1663280 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-31.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -15778000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -59607000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -49823000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -6344000 USD · 2026-01-01 – 2026-03-31 Source
Net income: 452000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-23.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -40289000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -30408000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -48204000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -40289000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -5267000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -5686000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -5267000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-20.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 1 of 11 periods available· newest 2021-12-31
Operating income: 7 of 11 periods available· newest 2025-12-31
Net income: 7 of 11 periods available· newest 2025-12-31
Operating cash flow: 7 of 11 periods available· newest 2025-12-31
capital expenditure: No compatible figures in this window
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 10.17 million

Prior period

−USD 69.78 million

2024-01-01 – 2024-12-31
Current period

−USD 59.61 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-59607000 − -69776000 = 10169000 USD

-69776000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-59607000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOATLA, INC. · 2025-12-31 BIOATLA, INC. (edgar:1826892) Year-over-year change in Net income: 10169000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -59607000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000119312526134499/bcab-20251231.htm#1807572 Filing: 000119312526134499 Input fundies:NetIncome: -69776000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000119312526134499/bcab-20251231.htm#1809328 Filing: 000119312526134499
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 23.73 million

Prior period

−USD 71.94 million

2024-01-01 – 2024-12-31
Current period

−USD 48.2 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-48204000 − -71936000 = 23732000 USD

-71936000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-48204000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOATLA, INC. · 2025-12-31 BIOATLA, INC. (edgar:1826892) Year-over-year change in Operating cash flow: 23732000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -48204000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000119312526134499/bcab-20251231.htm#1855504 Filing: 000119312526134499 Input fundies:OperatingCashFlow: -71936000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000119312526134499/bcab-20251231.htm#1857280 Filing: 000119312526134499
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 300,000 100% of revenue
Operating costs Derived USD 96.74 million 32,247% of revenue
Operating income −USD 96.44 million −32,147% of revenue
Tax, interest and other Derived −USD 1.04 million −346% of revenue
Net income −USD 95.4 million −31,801% of revenue

Cash

Operating cash flow −USD 62.21 million −20,738% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2021 Operating loss: operating costs were 32,247% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2021 2021-01-01 – 2021-12-31	300000	96740000 Derived	-96440000	-1038000 Derived	-95402000	Unavailable	Source 2021-01-01 – 2021-12-31: 300000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -96440000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -95402000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -62214000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 300K 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Revenue	300000	Revenue: 300000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Year over year	No prior comparable period	Revenue: 300000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -32,146.7% 2021

Net margin -31,800.7% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Operating margin	-32,146.7%	Operating Income: -96440000 Open source Revenue: 300000 Open source
20212021-12-31	Net margin	-31,800.7%	Net Income: -95402000 Open source Revenue: 300000 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 300000 Open source Operating Cash Flow: -62214000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -62.2M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Operating cash flow	-62214000	Operating Cash Flow: -62214000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -62214000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

17.1% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Liabilities / assets	17.1%	Total Liabilities: 43601000 Open source Total Assets: 254422000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

12.48× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Current assets / current liabilities	12.48×	Current Assets: 247292000 Open source Current Liabilities: 19813000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−USD 29.86 million Exact value Exact value: -29855000 USD 2019-01-01 – 2019-12-31: -29855000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOATLA, INC. · 2019-12-31 BIOATLA, INC. (edgar:1826892) Net Income: -29855000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29855000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000095017022002303/bcab-20211231.htm#2514877 Filing: 000095017022002303 The citation records this snapshot. The page link may show a newer release later.	−USD 9.65 million Exact value Exact value: -9645000 USD 2019-01-01 – 2019-12-31: -9645000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOATLA, INC. · 2019-12-31 BIOATLA, INC. (edgar:1826892) Operating Cash Flow: -9645000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9645000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000095017022002303/bcab-20211231.htm#2612240 Filing: 000095017022002303 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 35.85 million Exact value Exact value: -35853000 USD 2020-01-01 – 2020-12-31: -35853000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOATLA, INC. · 2020-12-31 BIOATLA, INC. (edgar:1826892) Net Income: -35853000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35853000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000095017022002303/bcab-20211231.htm#2512865 Filing: 000095017022002303 The citation records this snapshot. The page link may show a newer release later.	−USD 36.33 million Exact value Exact value: -36334000 USD 2020-01-01 – 2020-12-31: -36334000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOATLA, INC. · 2020-12-31 BIOATLA, INC. (edgar:1826892) Operating Cash Flow: -36334000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36334000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000095017022002303/bcab-20211231.htm#2610240 Filing: 000095017022002303 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 95.4 million Exact value Exact value: -95402000 USD 2021-01-01 – 2021-12-31: -95402000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOATLA, INC. · 2021-12-31 BIOATLA, INC. (edgar:1826892) Net Income: -95402000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -95402000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000095017023009551/bcab-20221231.htm#1974727 Filing: 000095017023009551 The citation records this snapshot. The page link may show a newer release later.	−USD 62.21 million Exact value Exact value: -62214000 USD 2021-01-01 – 2021-12-31: -62214000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOATLA, INC. · 2021-12-31 BIOATLA, INC. (edgar:1826892) Operating Cash Flow: -62214000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -62214000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000095017023009551/bcab-20221231.htm#2022409 Filing: 000095017023009551 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 106.48 million Exact value Exact value: -106482000 USD 2022-01-01 – 2022-12-31: -106482000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOATLA, INC. · 2022-12-31 BIOATLA, INC. (edgar:1826892) Net Income: -106482000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -106482000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000095017024036548/bcab-20231231.htm#1455511 Filing: 000095017024036548 The citation records this snapshot. The page link may show a newer release later.	−USD 90.42 million Exact value Exact value: -90420000 USD 2022-01-01 – 2022-12-31: -90420000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOATLA, INC. · 2022-12-31 BIOATLA, INC. (edgar:1826892) Operating Cash Flow: -90420000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -90420000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000095017024036548/bcab-20231231.htm#1479870 Filing: 000095017024036548 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−USD 123.46 million Exact value Exact value: -123462000 USD 2023-01-01 – 2023-12-31: -123462000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOATLA, INC. · 2023-12-31 BIOATLA, INC. (edgar:1826892) Net Income: -123462000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -123462000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000095017025046217/bcab-20241231.htm#1664114 Filing: 000095017025046217 The citation records this snapshot. The page link may show a newer release later.	−USD 104.02 million Exact value Exact value: -104015000 USD 2023-01-01 – 2023-12-31: -104015000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOATLA, INC. · 2023-12-31 BIOATLA, INC. (edgar:1826892) Operating Cash Flow: -104015000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -104015000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000095017025046217/bcab-20241231.htm#1698160 Filing: 000095017025046217 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2024-01-01 – 2024-12-31	−USD 69.78 million Exact value Exact value: -69776000 USD 2024-01-01 – 2024-12-31: -69776000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOATLA, INC. · 2024-12-31 BIOATLA, INC. (edgar:1826892) Net Income: -69776000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -69776000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000119312526134499/bcab-20251231.htm#1809328 Filing: 000119312526134499 The citation records this snapshot. The page link may show a newer release later.	−USD 71.94 million Exact value Exact value: -71936000 USD 2024-01-01 – 2024-12-31: -71936000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOATLA, INC. · 2024-12-31 BIOATLA, INC. (edgar:1826892) Operating Cash Flow: -71936000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -71936000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000119312526134499/bcab-20251231.htm#1857280 Filing: 000119312526134499 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	−USD 59.61 million Exact value Exact value: -59607000 USD 2025-01-01 – 2025-12-31: -59607000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOATLA, INC. · 2025-12-31 BIOATLA, INC. (edgar:1826892) Net Income: -59607000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -59607000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000119312526134499/bcab-20251231.htm#1807572 Filing: 000119312526134499 The citation records this snapshot. The page link may show a newer release later.	−USD 48.2 million Exact value Exact value: -48204000 USD 2025-01-01 – 2025-12-31: -48204000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOATLA, INC. · 2025-12-31 BIOATLA, INC. (edgar:1826892) Operating Cash Flow: -48204000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1826892/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48204000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1826892/000119312526134499/bcab-20251231.htm#1855504 Filing: 000119312526134499 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

42 filings · 1,340 latest values · 1,340 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001826892, 1826892, BCAB, edgar:1826892

Also known as BIOATLA, INC., BioAtla, Inc.

BIOATLA, INC.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation